Nuzenio

Welcoming Edgewise Therapeutics

Welcoming Edgewise Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 2 publisher sources 100/100 entity strength

Latest news

H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45 - MoomooMoomoo · Thu, 06 Aug 2026 21:31:00 GMTEdgewise Therapeutics Q2 Net Loss Widens to $57.3 Million - MoomooMoomoo · Thu, 06 Aug 2026 12:16:35 GMTEdgewise Therapeutics Gains as Investors Weigh Cash-rich Reset and Cardiovascular Pipeline Progress - MoomooMoomoo · Tue, 04 Aug 2026 21:26:08 GMTOlivier Laureau: Welcoming Edgewise Therapeutics to Servier and Opening a New Chapter for Patients - OncodailyOncodaily · Wed, 29 Jul 2026 12:33:35 GMT

Timeline

Thu, 06 Aug 2026 21:31:00 GMTH.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Thu, 06 Aug 2026 12:16:35 GMTEdgewise Therapeutics Q2 Net Loss Widens to $57.3 Million - Moomoo
Tue, 04 Aug 2026 21:26:08 GMTEdgewise Therapeutics Gains as Investors Weigh Cash-rich Reset and Cardiovascular Pipeline Progress - Moomoo
Wed, 29 Jul 2026 12:33:35 GMTOlivier Laureau: Welcoming Edgewise Therapeutics to Servier and Opening a New Chapter for Patients - Oncodaily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Welcoming Edgewise Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.